ANVISA registration

LIAISON TG GEN II

Registration 10339840505. TIREOGLOBULINA (TG) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER

Registration details

Registration number10339840505
Application number25351092469201926
Technical nameTIREOGLOBULINA (TG) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER
Risk classIII
Published on24/06/2019
ValidityValid until 01/09/2035

Registration holder

Legal nameDIASORIN LTDA
CNPJ01.896.764/0001-70

Manufacturer

  • DIASORIN ITALIA S.P.A. ITÁLIA

Other registrations held by DIASORIN LTDAview all

LIAISON Tg

10339840125

LIAISON T3

10339840126

LIAISON CA 15-3

10339840127

LIAISON FT3

10339840128

LIAISON CA 19-9

10339840129

LIAISON CA-125 II

10339840130

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist